chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Weakening of rotator cuffs and cracking of shoulders.  Occurs identically in both shoulders.  This occurred one week after Dose 2 as well, and persisted for several months, including a shoulder injury that occurred during non-strenuous activity (throwing frisbee), but was unreported.  I was unable to do work above my shoulders without tremendous pain for about 2 months.  I could not do pushups or military press without risking injury.  The condition improved after 3 months, and I was back to normal prior to getting boosted.  One day after getting boosted, the same weakness and joint cracking returned and has not abated.  This is not due to the physical administration of the vaccine because the pain/weakening is identical in both shoulders. The pharmacy staff who administered the vaccine did an outstanding job.
I have a 2 year old son, and I did not have any issues with my pregnancy. The estimated date of delivery for this unborn child was 06/15/2023. I had a couple of episodes of spotting between 4-5 weeks with right sided abdominal pain. I had an ultrasound to rule out ectopic pregnancy. The ultrasound showed an early intrauterine pregnancy so they scheduled another ultrasound follow-up. I got my flu/Covid shot on 10/24. After receiving the vaccines, I experienced a lot of back pain and increased nausea. I had the second ultrasound and it showed that the baby was measuring 6 days behind. I had a third ultrasound on 11/09, that showed the baby was continuing to measure behind and there was no longer a heartbeat. I had a DNC on 11/11/2022 because my body hadn't started doing anything on its own.
On 3/10/15 (235 pm vitals taken) Dad said she fainted in waiting room on way out of clinic. Approx 5-10 min post vaccination. Pt. alert when I got to her. Called for nurses to help. Pts stayed on floor, head between her knees, took WNL vitals, pt stated she was "going to throw up" offered her a sugar drink-pts stated she ate lunch today. Very clammy,-got her an ice pac. After thirty minutes she was up and "ok" she stated.
L arm hurt within a few hours. By midnight felt like I had 10 tetanus shots. At that time could not get warm but didn't have chills yet. By 2 am had chills and all bones and joints hurt head to toe so I took acetaminophen. Was able to get a little bit of sleep but pain and malaise increased overnight. By 10 am chills an low grade fever (101.8). By 12:30 pm, nausea and higher fever (102.7). Pain became excruciating so I took one 200 mg advil around 2 pm (>24 h post vaccination; figured immune repsponse already had ample time to kick in). Within an hour fever reduced back to around 101. Felt some reprieve by 4 pm, enough to get out of bed but still pain, malaise, low fever. Return of symptoms/signs by 9 pm (low grade fever, more malaise and body/joint pain, piercing headache - new symptom: seeing some blurry spots in field of vision). Took one more advil (200 mg) some time before bed (before 11) so I could sleep.  On 4/10 - random body pains and soreness. Teeth sensitivity and pain. Either rash or beginning of pitting edema on L arm near injection site. Very drained and tired physically but functional mentally.
Breakthrough infection of COVID-19. Triple full dose vaccination and tested positive on 12/27/2021 from test administered by a medical professional. Moderna mRNA vaccine: Dose 1, 03/12/2021. Dose 2, 04/09/2021. Dose 3, 09/02/2021. Symptoms: persistent dry non-productive cough, lower extremity joint swelling and pain.
First outbreak of herpes in "at least 7 years"; This case was reported by a nurse via call center representative and described the occurrence of herpes virus infection in a 67-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles (patient had a shingles outbreak 6 weeks ago) and herpes virus infection.   On 26th October 2020, the patient received the 1st dose of Shingrix (intramuscular). On 27th October 2020, 1 days after receiving Shingrix, the patient experienced herpes virus infection. On an unknown date, the outcome of the herpes virus infection was not recovered/not resolved.   It was unknown if the reporter considered the herpes virus infection to be related to Shingrix.  Additional details were provided as follows: The patient had received Shingrix on her left arm and on the next day, she had her first outbreak of herpes in at least 7 years. The reporter consented to follow-up and also gave consent to health care professional follow-up.
No prior reaction ever experienced from a vaccine or shot before other than slight pain in my arm.   This time, I experienced severe burning and pain in left arm that traveled down the arm immediately after the shot was received causing tears to my eyes. Also experienced a short bout of heart palpitations.  Burning dissipated over the course of the day. Pain in arm lasted 2 weeks with it still being tender as of today when palpitated.
Child ran a fever of 104.6 during the night after receiving the flu mist at noon on Thursday December 11.  Alternating Tylenol and Advil.  Temperature at 100.6 at time of this report.  Mother reported prior illness 1 week before with a temp of 104.8.  She also reported he had ran a temp of 100.7 the day before the vaccine was given.
Mom reported child had fever from 100 to 101F and child inconsolably screaming and crying for 2hrs. Child is usually pleasant and mild mannered.
left arm at administration site red, sl.swollen, warm to touch.  Seen in ER.  Prescribed Keflex, Diflucan.
This spontaneous report was received from a nurse, and refers to a patient of unknown age and gender. No information about the patient's medical history, concurrent conditions and concomitant medications was provided. On an unknown date, the patient was vaccinated with a dose of M-M-R II, intramuscularly, for prophylaxis (dose, frequency, lot number and expiration date were not provided). No adverse symptoms reported and no product quality complaint (PQC) was involved.
Red rash started on face then spread to body on 11/19/2019. Went to Clinic 11/19/2019- prescription given for Prednisone & Zyrtec - to take OTC Benadryl. Also Benadryl given by Clinic. Seen in office 11/20/19 was diagnose with suspected allergy to Influenza. Vaccine & entry under allergy changed to reflect allergy to Influenza Vaccine.
No adverse event; Patient received updated booster before primary series/Patient received the Moderna bivalent vaccine instead of the first dose of her Moderna primary series vaccine.; This spontaneous case was reported by a pharmacist and describes the occurrence of WRONG PRODUCT ADMINISTERED (Patient received updated booster before primary series/Patient received the Moderna bivalent vaccine instead of the first dose of her Moderna primary series vaccine.) and NO ADVERSE EVENT (No adverse event) in a 62-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7164B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 29-Oct-2022, the patient received first dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 29-Oct-2022, the patient experienced WRONG PRODUCT ADMINISTERED (Patient received updated booster before primary series/Patient received the Moderna bivalent vaccine instead of the first dose of her Moderna primary series vaccine.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (Patient received updated booster before primary series/Patient received the Moderna bivalent vaccine instead of the first dose of her Moderna primary series vaccine.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (Patient received updated booster before primary series/Patient received the Moderna bivalent vaccine instead of the first dose of her Moderna primary series vaccine.).    Concomitant medications were not reported.   The patient signed up to receive the Moderna Covid-19 vaccine bivalent dose on 31OCT2022. Patient was accidentally vaccinated on 29-Oct-2022 with Moderna COVID-19 Vaccine Bivalent before getting the primary series.  No treatment information was provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 31-Oct-2022: Live Follow-up received include :Suspect (Moderna Bivalent) Date of administration updated On 31-Oct-2022: Live Follow-up received include : Patient details updated, Suspect (Moderna Vaccine ) lot number added.
Irritable bowel syndrome with loose stools sometimes or watery stools at other times; Spontaneous report received on 13DEC2019.  A female consumer who is a physician reported that she had "irritable bowel syndrome (IBS) with loose stools sometimes or watery stools at other times" (PT: Irritable bowel syndrome), after administration of oral Vivotif for typhoid fever prophylaxis. On an unknown date in 2015, the consumer took the course of Vivotif. Then, after 2 weeks, she developed IBS. She had no abdominal pain but had different stool consistency, such as having loose stools sometimes or watery stools at other times. She stated that she usually pooped every day. She did not take any treatment for IBS. She was eating healthy. Action taken with Vivotif with respect to reported event was not applicable. After a few months, she was recovered from the event.  Consumer's medical history included inflammatory mass in colon so her descending colon was removed in 2011.  Reporter considered the event of "irritable bowel syndrome (IBS) with loose stools sometimes or watery stools at other times" related to Vivotif as she did not have a history of IBS.  Company Comment: A consumer completed Vivotif course, and after 2 weeks had irritable bowel syndrome with loose stools sometimes or watery stools at other times. The event resolved after a few months with out any treatment. Consumer had a history of descending colon removal for an inflammatory mass in colon a few years prior to taking Vivotif. Considering the potential of Vivotif to cause diarrhea, and the case information, the role of Vivotif cannot be ruled out, and the causality of the event is assessed as possible with Vivotif.; Sender's Comments: A consumer completed Vivotif course, and after 2 weeks had irritable bowel syndrome with loose stools sometimes or watery stools at other times. The event resolved after a few months with out any treatment. Consumer had a history of descending colon removal for an inflammatory mass in colon a few years prior to taking Vivotif. Considering the potential of Vivotif to cause diarrhea, and the case information, the role of Vivotif cannot be ruled out, and the causality of the event is assessed as possible with Vivotif.
consumed alcohol yesterday and was woozy afterwards; This is a spontaneous report from a contactable consumer (patient). A female patient of unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK9231) via unspecified route of administration on 05Jan2021 at single dose for COVID-19 immunization. Medical history included consume alcohol. Concomitant medications were not reported. Patient took the vaccine at work yesterday (05Jan2021), she works in the healthcare industry, and wants to know if after getting the vaccine can a person consume alcohol. The patient remarked that she did consume alcohol yesterday and was woozy afterwards. She read somewhere that a person should not consume alcohol for 2 months as the vaccine will not work as well. She wanted to know if this was true. Outcome of the event was unknown.
Pt had TDAP on (R) arm. Site is read, warm to touch. Pt states no fever, slightly pain. Advised pt to use ice pack if get worse see Provider.
Patient came to pharmacy complaining of pain,redness,warmth, and swelling in Left upper arm. Pneumovax vaccine given in left arm previous evening at our pharmacy. Patient had mobility and recommended to take acetaminophen, ice, benedryl and to contact primary care provider or urgent care if condition worsens
This spontaneous report as received from a other health professional refers to multiple unspecified patients of unknown ages. On an unknown dates the patients were vaccinated with M-M-R II lot # M039914, expiration date: 26-SEP-2018 for prophylaxis. On an unknown dates, the patient's experienced incorrect product storage and no adverse event. The outcome of incorrect product storage and no adverse event is unknown. The reporter considered incorrect product storage and no adverse event to be not related to M-M-R II. Sender's Comments: US-009507513-1709USA004393: US-009507513-1709USA004014.
Miscommunication between which vaccine she was inquiring about. received a Tdap when she now states she was looking for a shingrix. Still investigating  how it occured
vomiting with nausea; vomiting with nausea; body aches; dizziness; This is a spontaneous report from a contactable other healthcare professional (patient). A 53-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot/Batch number: EH9899) via intramuscular in left arm on 07Jan2021 11:00 as 1st dose, single for COVID-19 immunization (at the age of 53-years-old). Medical history included chronic regional pain syndrome form severe spinal cord injury. Patient had known allergies: Vicodin, sulfa. Concomitant medication(s) included gabapentin and morphine 30 mg, 1 daily. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Post vaccination, the patient had not been tested for COVID-19. Patient stated that after the first dose of the Covid vaccine on 04Feb2021 at 14:30 (within 2-3 hours), she was vomiting with nausea, body aches and dizziness for 3-5 days. The adverse events resulted in physician office visit. The clinical outcome for the events was not recovered.  Follow-up attempts are completed. No further information is expected.
Covid arm; arm of injection itchy; Arm of injection with a lamp; Arm of injection swollen; Headache; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (Arm of injection with a lamp), HYPERSENSITIVITY (Covid arm), VACCINATION SITE SWELLING (Arm of injection swollen), HEADACHE (Headache) and VACCINATION SITE PRURITUS (arm of injection itchy) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure and Diabetes.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, the patient experienced VACCINATION SITE MASS (Arm of injection with a lamp), VACCINATION SITE SWELLING (Arm of injection swollen) and HEADACHE (Headache). On 07-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (arm of injection itchy). On an unknown date, the patient experienced HYPERSENSITIVITY (Covid arm). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE MASS (Arm of injection with a lamp), VACCINATION SITE SWELLING (Arm of injection swollen), HEADACHE (Headache) and VACCINATION SITE PRURITUS (arm of injection itchy) had not resolved and HYPERSENSITIVITY (Covid arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient take medicine for blood pressure and medicine for diabetes in concomitant medication.  Patient take Tylenol and ice as a Treatment medication
Patient was brought to the inner facility lobby at approx 3:15pm. Patient observation time was over at this point, but she was reporting generalized itching, with her skin on her arms feeling red and warm. Client was provided a cool gel pack to apply to affected areas. Client denied any swelling in the mouth or throat, also no difficulty breathing. No hives or rash observed. As the skin irritation progressed to include her arms, right leg, back and scalp staff decided to administer IM Diphenhydramine. Client was escorted to room. 2 RN's  confimed correct dosase for pt weight. 50mg/1ml for 100kg (220lb). RN administered the medication to the left deltoid at 3:21pm. Client reported feeling improvement by 3:23pm, further improvement by 3:28pm skin still feeling warm to touch. NP also assessed the client and provided instructions for emergency treatment if needed, and the use of over the counter medications Pepcid and Benadryl every 8 hours as needed. Client was provided with a bottle of water for dry mouth. RN continued to observe client until 3:51pm. At this time the client reported feeling significantly less ithcing, now getting drowsy from the medication. No hives or difficulty breathing had occurred during observation. RN escorted the client to her car. Client's husband was driving her today and verbalized understanding of emergency and over the counter instructions. RN will complete a VAERS report.
After receiving the vaccine, I had body aches all over and just didn't feel good. Tested 07/24 I tested negative for COVID-19. On Tuesday, July 26 I tested positive for COVID-19. On 07/27 I had a car (parking lot) visit with my doctor. I was given a prescription for PAXLOVID, benzonatate and to use MUCINEX D.
10.5 cm x 8 cm rash left arm. Received varicella vaccine on 5/3/16. Rash noted on 5/5/16. Hydrocortisone 1% applied with ice and ace wrap.
Rash on neck and chest, left arm went numb. Injection site was left deltoid.  Nov 8th, 2013 went to ER for severe allergic reaction. Throat closing, blurred vision/no vision, left side was paralyzed. Slurred speech, pain throughout entire body. Heart racing.
She reported having PAC via her fitness watch. She said this was a new event for her last a few hours.
At approx 10-15 minutes post injection patient was with his mother at our counter when he became faint. His mother eased him to the floor. He came to quickly but remained weak for a few minutes. at 4:30pm BP 118/72 P 57, alert. 4:40 - 145/80 P 68, 4:50 12272 P 62. Left the office at 4:55 fully alert and no c/o's.
While driving home (Approx 50 minutes after receiving vaccine), tingling lips, itchy mouth, swollen tongue, tight chest.  Went to urgent care
Vomiting immediately & continued with diarrhea 2 days later. Dr. appt. 6/8/10 - He felt intestinal illness same as another family member. Continues diarrhea only 6/9/10 otherwise no other symptoms per mother.
Patient stated she had severe arm pain after the vaccine that got worse as the day went on. Patient stated that the pain was so bad she passed out in her bathroom at 3:30am and her husband had to call 911. Patient was taken to the hospital and had a broken nose as a result of passing out and falling.
Lt arm up to shoulder down arm from inject site; inflammed itching; afebrile; unsure when rxn started;
2ND SHOT OF ANTHRAX VACCINE CAUSED SHINGLES OUTBREAK.  oCCURED SAME DAY AND PROGESSIVELY GOT WORSE.
Experienced an allergic reaction / Doctor needs to run her some skin test; This case was reported by a consumer via call center representative and described the occurrence of allergic skin reaction in a female patient who received Flu Seasonal QIV Dresden (Fluarix Tetra 2020-2021 season) for prophylaxis.   Co-suspect products included flu seasonal qiv dresden pre-filled syringe device (Fluarix Tetra Pre-Filled Syringe Device) injection syringe for prophylaxis.   On an unknown date, the patient received Fluarix Tetra 2020-2021 season and Fluarix Tetra Pre-Filled Syringe Device. On an unknown date, less than 9 months after receiving Fluarix Tetra 2020-2021 season and Fluarix Tetra Pre-Filled Syringe Device, the patient experienced allergic skin reaction. On an unknown date, the outcome of the allergic skin reaction was unknown.   It was unknown if the reporter considered the allergic skin reaction to be related to Fluarix Tetra 2020-2021 season and Fluarix Tetra Pre-Filled Syringe Device.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional information was provided as follows: This case was reported by patient herself. The age at vaccination was not reported. The patient after receiving Fluarix QIV vaccine she experienced an allergic reaction and now the doctor needed to run her some skin test. The patient wanted to know how to get a pharmacy to fill Fluarix without administrating it. She suggested the prescriber call VSC (vaccine service center) but caller said that prescriber just wanted one dose. The reporter had prescriber (allergist) follow up with VSC (vaccine service center). No further clarifications were made. The reporter did not mentioned (consent or denied) regarding consented to follow up.
No other AE reported; temperature excursion involving VARlVAX / some of the vaccines were administered; This spontaneous report as received from an office manager refers to a patient of unknown age.and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided.  On 09-FEB-2021, the patient was vaccinated with an improperly stored dose varicella virus vaccine live (oka/merck) (VARIVAX) 0.5 ml, lot # T021826, expiration date 25-JUN-2022 (route of administration was not provided) for prophylaxis. The administered dose of vaccine experienced temperature excursion of -9.52 degrees Celsius for 56 minutes. There was no previous temperature excursion reported. The digital data logger was involved. There was no adverse event reported.  This is ne of several cases received from the same reporter.; Sender's Comments:  US-009507513-2102USA005039: US-009507513-2102USA004607: US-009507513-2102USA005061:
Pulsation, chest pain, elevated B / P, disorientation, vision distortion, and dizziness.
I was extreamly sick and ended up at my doctor's office.  I have not had my period since my shot.
Blistery rash on my face that won?t go away and has spread. It started a couple of weeks after I had the shot.
Bodyache; Temperature is 98.6 ° F but she feels hot inside; Chills; Injection site swelling; Injection site pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Bodyache), PYREXIA (Temperature is 98.6 ° F but she feels hot inside), CHILLS (Chills), VACCINATION SITE SWELLING (Injection site swelling) and VACCINATION SITE PAIN (Injection site pain) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Apr-2021, the patient experienced VACCINATION SITE SWELLING (Injection site swelling) and VACCINATION SITE PAIN (Injection site pain). On 08-Apr-2021, the patient experienced PAIN (Bodyache), PYREXIA (Temperature is 98.6 ° F but she feels hot inside) and CHILLS (Chills). The patient was treated with IBUPROFEN at an unspecified dose and frequency and DICYCLOMINE [DICYCLOVERINE] at an unspecified dose and frequency. At the time of the report, PAIN (Bodyache), PYREXIA (Temperature is 98.6 ° F but she feels hot inside), CHILLS (Chills), VACCINATION SITE SWELLING (Injection site swelling) and VACCINATION SITE PAIN (Injection site pain) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Apr-2021, Body temperature: 98.6 (High) 98.6 ° F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication use was not provided.